Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Hyun Su, Min"'
Autor:
Yu Na Lim, In Soo Ryu, Yeon-Joo Jung, Gabriel Helmlinger, Insun Kim, Hye Won Park, Hansol Kang, Jina Lee, Hyo Jin Lee, Kang Seon Lee, Ha-Na Jang, Dae-In Ha, Junghyung Park, Jinyoung Won, Kyung Seob Lim, Chang-Yeop Jeon, Hyun-Jeong Cho, Hyun Su Min, Jin-Hyeob Ryu
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 35, Iss 4, Pp 102340- (2024)
l-Type amino acid transporter 1 (LAT1)-specific ligands and polyion complexes are used as brain-specific targets to deliver RNA-based drugs across the blood-brain barrier. We characterized an LAT1-targeting antisense oligonucleotide (ASO)-encapsulate
Externí odkaz:
https://doaj.org/article/75ccd5988ffe4c2d820c0368db49aea4
Autor:
Jeong, Da Eun, Hyun, Su Min, Cho, Iseop, Lee, Kyong-No, Ahn, Kwanghee, Ji Kim, Hyeon, Yoon Park, Jee, Oh, Kyung Joon
Publikováno v:
In Taiwanese Journal of Obstetrics & Gynecology May 2022 61(3):441-446
Autor:
Mao Hori, Kotaro Hayashi, Akihiro Kishimura, Tetsuya Nagata, Yasutaka Anraku, Kazunori Kataoka, Yu Yi, Kanjiro Miyata, Beob Soo Kim, Mitsuru Naito, Hyun Su Min, Hyun Jin Kim, Hiroyuki Chaya
Publikováno v:
Biomacromolecules. 21:4365-4376
For the simultaneous delivery of antisense oligonucleotides and their effector enzymes into cells, nanosized vesicular polyion complexes (PICs) were fabricated from oppositely charged polyion-pairs of oligonucleotides and poly(ethylene glycol) (PEG)-
Autor:
Kotaro Hayashi, Yasutaka Anraku, Hyun Jin Kim, Mitsuru Naito, Shigeto Fukushima, Satomi Ogura, Kazuko Toh, Kanjiro Miyata, Beob Soo Kim, Kazunori Kataoka, Hyun Su Min
Publikováno v:
Angewandte Chemie (International Ed. in English)
Current antisense oligonucleotide (ASO) therapies for the treatment of central nervous system (CNS) disorders are performed through invasive administration, thereby placing a major burden on patients. To alleviate this burden, we herein report system
Autor:
Hyun Jin Kim, Kazuko Toh, Mitsuru Naito, Ick Chan Kwon, Beob Soo Kim, Shigehito Osawa, Hyun Su Min, Yu Yi, Kanjiro Miyata, Kazunori Kataoka, Kotaro Hayashi
Publikováno v:
ACS Biomaterials Science & Engineering. 5:5770-5780
For intravenous delivery of antisense oligonucleotides (ASOs) to solid tumors, a triblock copolymer was synthesized from poly(2-ethyl-2-oxazoline) (PEtOx), poly(2-n-propyl-2-oxazoline) (PnPrOx), an...
Autor:
Keunsoo Jeong, Ji Young Yhee, Soo Young Park, Jeongyun Heo, Yong Deok Lee, Young Hun Seo, Kyung Eun Lee, Hyun Su Min, Chang Keun Lim, Ick Chan Kwon, Kwangmeyung Kim, Sehoon Kim
Publikováno v:
Chemistry of Materials. 31:2905-2912
Microbubbles are clinically used as an imaging agent for contrast-enhanced ultrasound image. Beyond the preformed microbubbles, nanoscale gas-generating chemical systems that are capable of stimulu...
Publikováno v:
In Journal of Controlled Release 2008 126(2):122-129
Autor:
Beob Soo, Kim, Mitsuru, Naito, Hiroyuki, Chaya, Mao, Hori, Kotaro, Hayashi, Hyun Su, Min, Yu, Yi, Hyun Jin, Kim, Tetsuya, Nagata, Yasutaka, Anraku, Akihiro, Kishimura, Kazunori, Kataoka, Kanjiro, Miyata
Publikováno v:
Biomacromolecules. 21(10)
For the simultaneous delivery of antisense oligonucleotides and their effector enzymes into cells, nanosized vesicular polyion complexes (PICs) were fabricated from oppositely charged polyion pairs of oligonucleotides and poly(ethylene glycol) (PEG)
Autor:
Jae-Young Lee, Ji Young Yhee, Sangmin Lee, Ick Chan Kwon, Hyun Su Min, Kuiwon Choi, Dong Gil You, Kinam Park, Tae Woong Lee, Sun Hwa Kim, Sejin Son, Jangwook Lee, Kwangmeyung Kim, Moon Hee Han, Jae Hyung Park
Publikováno v:
Biomaterials. 108:57-70
Although there is great versatility of ultrasound (US) technologies in the real clinical field, one main technical challenge is the compromising of high quality of echo properties and size engineering of ultrasound contrast agents (UCAs); a high echo
Autor:
Kuen Yong Lee, Ick Chan Kwon, Kwangmeyung Kim, Jangwook Lee, Hyun Su Min, Taiyoun Rhim, Dong Gil You
Publikováno v:
Journal of Controlled Release. 223:197-206
The development of safe and efficient diagnostic/therapeutic agents for treating cancer in clinics remains challenging due to the potential toxicity of conventional agents. Although the annual incidence of neuroblastoma is not that high, the disease